A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation

In light of the favorable outcomes of few small, non-randomized clinical studies, the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to Hydroxychloroquine (HCQ) for hospitalized coronavirus disease 2019 (COVID-19) patients. In fact, subsequent clinical studies wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Anand Prakash, Tousif, Sultan, Umbarkar, Prachi, Lal, Hind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355808/
https://www.ncbi.nlm.nih.gov/pubmed/32549293
http://dx.doi.org/10.3390/jcm9061867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7355808/
https://www.ncbi.nlm.nih.gov/pubmed/32549293
http://dx.doi.org/10.3390/jcm9061867

Ejemplares similares